|
1
|
Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme.
|
J Neurooncol
|
2001
|
1.02
|
|
2
|
The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients.
|
Eur J Cancer
|
2012
|
0.98
|
|
3
|
Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate.
|
J Neurooncol
|
1999
|
0.93
|
|
4
|
Modulation of tissue factor on human monocytes by cisplatin and adriamycin.
|
Br J Haematol
|
1992
|
0.89
|
|
5
|
Glutamate ameliorates experimental vincristine neuropathy.
|
J Pharmacol Exp Ther
|
1996
|
0.88
|
|
6
|
Current status of treatment for breast cancer.
|
Ann Acad Med Singapore
|
1990
|
0.76
|
|
7
|
Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix.
|
Gynecol Oncol
|
1992
|
0.75
|
|
8
|
Bone presentation of non-Hodgkin's lymphoma: experience at the Royal North Shore Hospital, Sydney; highlighting primary bone lymphoma.
|
Aust N Z J Med
|
1994
|
0.75
|